HD

Han-Qing Dong

OP Osi Pharmaceuticals: 10 patents #15 of 181Top 9%
DI Dana-Farber Cancer Institute: 1 patents #698 of 1,343Top 55%
📍 Boston, MA: #670 of 5,993 inventorsTop 15%
🗺 Massachusetts: #11,548 of 88,656 inventorsTop 15%
Overall (All Time): #432,712 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12227548 Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses Laurie H. Glimcher 2025-02-18
8796455 Fused bicyclic mTOR inhibitors Xin Chen, Heather R. Coate, Andrew Philip Crew, Ayako Honda, Mark J. Mulvihill +12 more 2014-08-05
8314111 Fused bicyclic motor inhibitors Xin Chen, Heather R. Coate, Andrew Philip Crew, Ayako Honda, Mark J. Mulvihill +11 more 2012-11-20
7943767 Fused bicyclic mTOR inhibitors Xin Chen, Heather R. Coate, Andrew Philip Crew, Ayako Honda, Mark J. Mulvihill +12 more 2011-05-17
7767673 N-substituted imidazopyridine c-Kit inhibitors Arlindo L. Castelhano, Andrew P. Crew, Radoslaw Laufer, An-Hu Li, Li Qiu +2 more 2010-08-03
7700594 Fused bicyclic mTOR inhibitors Xin Chen, Heather R. Coate, Andrew Philip Crew, Ayako Honda, Mark J. Mulvihill +12 more 2010-04-20
7648987 Bicyclic protein kinase inhibitors Andrew Philip Crew, Mark J. Mulvihill, Douglas S. Werner, Mridula Kadalbajoo, Radoslaw Laufer 2010-01-19
7521448 N-substituted benzimidazolyl c-Kit inhibitors Joshua Bolger, Arlindo L. Castelhano, Andrew P. Crew, Ayako Honda, Radoslaw Laufer +7 more 2009-04-21
7498354 Pyrrolo[2,3-D]imidazoles for the treatment of hyperproliferative disorders Andrew Philip Crew, Bijoy Panicker 2009-03-03
7459554 Imidazopyrazine tyrosine kinase inhibitors Kenneth Foreman, Mark J. Mulvihill, Anthony Nigro, Arno G. Steinig, Douglas S. Werner +1 more 2008-12-02
7442709 N3-substituted imidazopyridine c-Kit inhibitors Arlindo L. Castelhano, Andrew P. Crew, Radoslaw Laufer, An-Hu Li, Li Qiu +2 more 2008-10-28